hartwigmedical/actin
Mar 2025 – Aug 2025
6 Months active
Languages Used
KotlinJava
Technical Skills
API IntegrationCode OrganizationDependency ManagementModularityPDF GenerationRefactoring
Arno de Quaasteniet
PROFILE
Arno De Quaasteniet
Over six months, Arjan de Quaasteniet enhanced the hartwigmedical/actin repository by building modular backend features for clinical trial data processing and reporting. He refactored core modules to support reusable trial interpretation, extended data models for molecular evidence, and streamlined reporting pipelines for maintainability. Using Kotlin and Java, Arjan introduced robust API development and integration patterns, improved PDF generation with iText, and implemented configurable command-line interfaces. His work emphasized code organization, dependency management, and comprehensive unit testing, resulting in more reliable data extraction, easier onboarding of new trial data, and improved auditability for downstream analytics and automated reporting workflows.
Overall Statistics
Feature vs Bugs
90%Features
Repository Contributions
13Total
Bugs
1
Commits
13
Features
9
Lines of code
2,203
Activity Months6
Your Network
50 peopleSame Organization
@hartwigmedicalfoundation.nl29
Work History
August 2025
2 Commits • 1 Features
Aug 1, 2025Performance highlights for 2025-08: Delivered an API extension enabling OncoACTIN to utilize external trial data through an optional external-trials set in the TrialsProvider, while preserving existing default behavior. Implemented an explicit fix for OncoPanel version identification by pinning the panel version to a specific date, ensuring accurate data extraction in targeted experiments. These changes enhance data completeness and reliability for external data integrations and experimental analyses. Technical work emphasized backward-compatible API design, conditional data flows, and robust versioning strategies, laying groundwork for smoother onboarding of external data sources and more dependable downstream analytics.
2 Commits • 1 Features
Aug 1, 2025Performance highlights for 2025-08: Delivered an API extension enabling OncoACTIN to utilize external trial data through an optional external-trials set in the TrialsProvider, while preserving existing default behavior. Implemented an explicit fix for OncoPanel version identification by pinning the panel version to a specific date, ensuring accurate data extraction in targeted experiments. These changes enhance data completeness and reliability for external data integrations and experimental analyses. Technical work emphasized backward-compatible API design, conditional data flows, and robust versioning strategies, laying groundwork for smoother onboarding of external data sources and more dependable downstream analytics.
August 2025
July 2025
1 Commits • 1 Features
Jul 1, 2025July 2025 (2025-07) monthly summary for hartwigmedical/actin: Delivered a feature to customize the report date in the Reporter Application, enabling fixed dates via a command-line argument for report generation. This enhances reproducibility, auditability, and automation readiness of reporting workflows. The work is tracked under ACTIN-2184 (#1224) and committed as 3b4770f2a56b5e3c7fcee44151daf5c15ea6f01a. No major bugs fixed this month in this scope. Technologies demonstrated include CLI argument parsing, maintainable code design, and strong change traceability.
July 2025
1 Commits • 1 Features
Jul 1, 2025July 2025 (2025-07) monthly summary for hartwigmedical/actin: Delivered a feature to customize the report date in the Reporter Application, enabling fixed dates via a command-line argument for report generation. This enhances reproducibility, auditability, and automation readiness of reporting workflows. The work is tracked under ACTIN-2184 (#1224) and committed as 3b4770f2a56b5e3c7fcee44151daf5c15ea6f01a. No major bugs fixed this month in this scope. Technologies demonstrated include CLI argument parsing, maintainable code design, and strong change traceability.
June 2025
1 Commits • 1 Features
Jun 1, 2025June 2025 summary for hartwigmedical/actin: Delivered unfiltered retrieval of external clinical trials by refactoring TrialsProvider to support unfiltered access while preserving existing filtering paths. Updated and expanded the test suite to validate new behavior and regression coverage. No major bugs fixed this month; focus was on feature delivery and test coverage to enable broader data access and downstream analytics.
1 Commits • 1 Features
Jun 1, 2025June 2025 summary for hartwigmedical/actin: Delivered unfiltered retrieval of external clinical trials by refactoring TrialsProvider to support unfiltered access while preserving existing filtering paths. Updated and expanded the test suite to validate new behavior and regression coverage. No major bugs fixed this month; focus was on feature delivery and test coverage to enable broader data access and downstream analytics.
June 2025
May 2025
5 Commits • 3 Features
May 1, 2025May 2025 (hartwigmedical/actin): Delivered core feature work across testing utilities, data modeling, and reporting to strengthen test stability, data integrity, and maintainability. Key business value includes more reliable Java-friendly test utilities, a robust treatment data model with a default to drug class, and a streamlined trial reporting pipeline that reduces complexity and onboarding time for data consumers.
May 2025
5 Commits • 3 Features
May 1, 2025May 2025 (hartwigmedical/actin): Delivered core feature work across testing utilities, data modeling, and reporting to strengthen test stability, data integrity, and maintainability. Key business value includes more reliable Java-friendly test utilities, a robust treatment data model with a default to drug class, and a streamlined trial reporting pipeline that reduces complexity and onboarding time for data consumers.
April 2025
2 Commits • 1 Features
Apr 1, 2025April 2025: Delivered molecular evidence data model enhancements and trial data integration for hartwigmedical/actin. Extended the trial data model with new fields and refined structures to better represent trial information and molecular evidence. Added new evidence types, improved extraction/representation of molecular evidence, and performed refactoring and bug fixes to ensure data integrity and consistency. Simplified data by removing redundant flags and standardizing URL fields to improve reliability and maintainability. These changes enable more accurate analytics, easier integration of future trial data, and a more maintainable data platform.
2 Commits • 1 Features
Apr 1, 2025April 2025: Delivered molecular evidence data model enhancements and trial data integration for hartwigmedical/actin. Extended the trial data model with new fields and refined structures to better represent trial information and molecular evidence. Added new evidence types, improved extraction/representation of molecular evidence, and performed refactoring and bug fixes to ensure data integrity and consistency. Simplified data by removing redundant flags and standardizing URL fields to improve reliability and maintainability. These changes enable more accurate analytics, easier integration of future trial data, and a more maintainable data platform.
April 2025
March 2025
2 Commits • 2 Features
Mar 1, 2025March 2025 performance summary for hartwigmedical/actin focusing on delivering reusable trial interpretation capabilities and improved reporting fidelity. Key outcomes include: OncoACT Trial Interpretation Module — refactor to reusable module and introduced the TrialsProvider class to encapsulate trial presentation and interpretation; added Source field to ExternalTrialSummary for provenance tracking. PDF rendering upgrade — upgraded iText to 1.9.0 with updated API and corrected bold/italic styling in generated reports. Business value: reduced duplication, faster onboarding for new trials, improved provenance and auditability, and more reliable client reports. Technologies/skills demonstrated: modular design, provider pattern, API evolution, dependency upgrade (iText), and robust report generation.
March 2025
2 Commits • 2 Features
Mar 1, 2025March 2025 performance summary for hartwigmedical/actin focusing on delivering reusable trial interpretation capabilities and improved reporting fidelity. Key outcomes include: OncoACT Trial Interpretation Module — refactor to reusable module and introduced the TrialsProvider class to encapsulate trial presentation and interpretation; added Source field to ExternalTrialSummary for provenance tracking. PDF rendering upgrade — upgraded iText to 1.9.0 with updated API and corrected bold/italic styling in generated reports. Business value: reduced duplication, faster onboarding for new trials, improved provenance and auditability, and more reliable client reports. Technologies/skills demonstrated: modular design, provider pattern, API evolution, dependency upgrade (iText), and robust report generation.
Activity
Loading activity data...
Quality Metrics
Correctness85.4%
Maintainability88.4%
Architecture82.4%
Performance77.0%
AI Usage20.0%
Skills & Technologies
Programming Languages
JavaKotlin
Technical Skills
API DevelopmentAPI IntegrationBackend DevelopmentCode OrganizationCommand Line InterfaceConfiguration ManagementData ModelingData ProcessingDependency ManagementKotlinModularityPDF GenerationRefactoringSoftware DesignTest Data Generation
Repositories Contributed To
Overview of all repositories you've contributed to across your timeline